• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹膜间皮瘤患者端粒酶逆转录酶(TERT)mRNA水平与临床病理特征分析

Analysis of TERT mRNA Levels and Clinicopathological Features in Patients with Peritoneal Mesothelioma.

作者信息

d'Amati Antonio, Serio Gabriella, Quaranta Andrea, Vimercati Luigi, De Giorgis Michelina, Lorusso Loredana, Errede Mariella, Longo Vito, Marzullo Andrea, Ribatti Domenico, Annese Tiziana

机构信息

Department of Medicine and Surgery, LUM University, Casamassima, 70010 Bari, Italy.

Department of Translational Biomedicine and Neuroscience, University of Bari Medical School, 70124 Bari, Italy.

出版信息

Cancers (Basel). 2025 Jan 14;17(2):252. doi: 10.3390/cancers17020252.

DOI:10.3390/cancers17020252
PMID:39858033
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11764446/
Abstract

BACKGROUND/OBJECTIVES: Telomerase reverse transcriptase (TERT) is the catalytic subunit of the telomerase enzyme responsible for telomere length maintenance and is an important cancer hallmark. Our study aimed to clarify the mRNA expression of TERT in peritoneal mesothelioma (PeM), and to explore the relationship between its expression and the clinicopathological parameters and prognosis of patients with PeM.

METHODS

In a cohort of 13 MpeM patients, we evaluated histotype, nuclear grade, mitotic count, necrosis, inflammation, Ki67, BAP1, MTAP and p16 expression by immunohistochemistry, / status by FISH and TERT mRNA expression by RNAscope.

RESULTS

Our results showed several statistical correlations between TERT mRNA-score and other investigated features: (i) a poor positive correlation with BAP1 score ( = 0.06340; ≤ 0.0001); (ii) a moderate positive correlation with FISH del homo ( = 0.6340; ≤ 0.0001); (iii) a fair negative correlation with FISH del hetero ( = -0.3965; ≤ 0.0001); a negative poor correlation with MTAP ( = -0.2443; ≤ 0.0001); and (iv) a negative fair correlation with inflammatory infiltrate (r = -0.5407; = 0.0233). Moreover, patients survive for a significantly longer time if they have a low mitotic index adjusted (2-4 mitotic figures per 2 mm) ( ≤ 0.0001), are male ( = 0.0152), lose BAP1 ( = 0.0152), are p16 positive and present no deletion or heterozygous for ( ≤ 0.01).

CONCLUSIONS

TERT is highly expressed in PeM, but it is not one of the crucial factors in evaluating the prognosis of patients. Nevertheless, the results validate the prognostic significance of the mitotic index, BAP1 loss and /CDKN2A status.

摘要

背景/目的:端粒酶逆转录酶(TERT)是端粒酶的催化亚基,负责维持端粒长度,是一个重要的癌症标志。我们的研究旨在阐明TERT在腹膜间皮瘤(PeM)中的mRNA表达,并探讨其表达与PeM患者临床病理参数及预后之间的关系。

方法

在一组13例PeM患者中,我们通过免疫组织化学评估组织学类型、核分级、有丝分裂计数、坏死、炎症、Ki67、BAP1、MTAP和p16表达,通过荧光原位杂交(FISH)评估/状态,通过RNAscope评估TERT mRNA表达。

结果

我们的结果显示TERT mRNA评分与其他研究特征之间存在若干统计学相关性:(i)与BAP1评分呈弱正相关(=0.06340;≤0.0001);(ii)与FISH del homo呈中度正相关(=0.6340;≤0.0001);(iii)与FISH del hetero呈中等负相关(=-0.3965;≤0.0001);与MTAP呈弱负相关(=-0.2443;≤0.0001);(iv)与炎症浸润呈中等负相关(r=-0.5407;=0.0233)。此外,如果患者的有丝分裂指数调整后较低(每2mm有2 - 4个有丝分裂象)(≤0.0001)、为男性(=0.0152)、缺失BAP1(=0.0152)、p16阳性且不存在/缺失或杂合(≤0.01),则患者存活时间显著更长。

结论

TERT在PeM中高表达,但它不是评估患者预后的关键因素之一。然而,这些结果验证了有丝分裂指数、BAP1缺失和/CDKN2A状态的预后意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197c/11764446/c03ddcb7bede/cancers-17-00252-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197c/11764446/8196efa51f47/cancers-17-00252-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197c/11764446/c4052dbc149b/cancers-17-00252-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197c/11764446/09df3a0431ea/cancers-17-00252-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197c/11764446/566928cd888d/cancers-17-00252-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197c/11764446/c03ddcb7bede/cancers-17-00252-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197c/11764446/8196efa51f47/cancers-17-00252-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197c/11764446/c4052dbc149b/cancers-17-00252-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197c/11764446/09df3a0431ea/cancers-17-00252-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197c/11764446/566928cd888d/cancers-17-00252-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197c/11764446/c03ddcb7bede/cancers-17-00252-g005.jpg

相似文献

1
Analysis of TERT mRNA Levels and Clinicopathological Features in Patients with Peritoneal Mesothelioma.腹膜间皮瘤患者端粒酶逆转录酶(TERT)mRNA水平与临床病理特征分析
Cancers (Basel). 2025 Jan 14;17(2):252. doi: 10.3390/cancers17020252.
2
The significance of BAP1 and MTAP/CDKN2A expression in well-differentiated papillary mesothelial tumour: a series of 21 cases and a review of the literature.BAP1 和 MTAP/CDKN2A 表达在分化良好的乳头状间皮瘤中的意义:21 例系列病例及文献复习。
Pathology. 2024 Aug;56(5):662-670. doi: 10.1016/j.pathol.2024.02.016. Epub 2024 May 9.
3
Investigation of MTAP and BAP1 staining loss and P16/CDKN2A deletion in pleural cytology specimens and its role in the diagnosis of mesothelioma.胸腔细胞学标本中 MTAP 和 BAP1 染色丢失及 P16/CDKN2A 缺失的研究及其在间皮瘤诊断中的作用。
Diagn Cytopathol. 2024 Apr;52(4):211-216. doi: 10.1002/dc.25272. Epub 2024 Jan 20.
4
Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: Comparison with 9p21 FISH and BAP1 immunohistochemistry.免疫组化检测 MTAP 和 BAP1 蛋白缺失在间皮瘤诊断中的应用:与 9p21 FISH 和 BAP1 免疫组化的比较。
Lung Cancer. 2017 Feb;104:98-105. doi: 10.1016/j.lungcan.2016.12.017. Epub 2016 Dec 23.
5
Methylthioadenosine Phosphorylase and Breast Cancer 1 Protein-Associated Protein 1 as Biomarkers for the Peritoneal Mesothelioma.甲硫腺苷磷酸化酶和乳腺癌 1 蛋白相关蛋白 1 作为腹膜间皮瘤的生物标志物。
Cancer Control. 2023 Jan-Dec;30:10732748231220805. doi: 10.1177/10732748231220805.
6
Prognostic Value of Ki67 Percentage, WT-1 Expression and p16/CDKN2A Deletion in Diffuse Malignant Peritoneal Mesothelioma: A Single-Centre Cohort Study.Ki67百分比、WT-1表达及p16/CDKN2A缺失在弥漫性恶性腹膜间皮瘤中的预后价值:一项单中心队列研究
Diagnostics (Basel). 2020 Jun 9;10(6):386. doi: 10.3390/diagnostics10060386.
7
New Insights on Diagnostic Reproducibility of Biphasic Mesotheliomas: A Multi-Institutional Evaluation by the International Mesothelioma Panel From the MESOPATH Reference Center.双相性间皮瘤诊断可重复性的新见解:来自 MESOPATH 参考中心的国际间皮瘤专家组的多机构评估。
J Thorac Oncol. 2018 Aug;13(8):1189-1203. doi: 10.1016/j.jtho.2018.04.023. Epub 2018 Apr 30.
8
BAP1 immunohistochemistry has limited prognostic utility as a complement of CDKN2A (p16) fluorescence in situ hybridization in malignant pleural mesothelioma.作为恶性胸膜间皮瘤中CDKN2A(p16)荧光原位杂交的补充,BAP1免疫组化的预后效用有限。
Hum Pathol. 2017 Feb;60:86-94. doi: 10.1016/j.humpath.2016.09.026. Epub 2016 Oct 19.
9
Fluorescence in situ hybridization (FISH) provides estimates of minute and interstitial BAP1, CDKN2A, and NF2 gene deletions in peritoneal mesothelioma.荧光原位杂交(FISH)可估算腹膜间皮瘤中微小和间质 BAP1、CDKN2A 和 NF2 基因缺失。
Mod Pathol. 2020 Feb;33(2):217-227. doi: 10.1038/s41379-019-0371-0. Epub 2019 Sep 30.
10
Contribution of BAP1 loss and p16 (CDKN2A) deletion analysis to the definitive diagnosis of mesothelioma in effusion cytology.胸腔积液细胞学中 BAP1 缺失和 p16(CDKN2A)缺失分析对间皮瘤明确诊断的贡献。
Eur Rev Med Pharmacol Sci. 2023 Oct;27(20):10001-10007. doi: 10.26355/eurrev_202310_34180.

本文引用的文献

1
The absence of telomerase leads to immune response and tumor regression in zebrafish melanoma.端粒酶的缺失导致斑马鱼黑色素瘤中的免疫反应和肿瘤消退。
Cell Rep. 2024 Dec 24;43(12):115035. doi: 10.1016/j.celrep.2024.115035. Epub 2024 Dec 4.
2
The Molecular Landscape of 227 Adult Granulosa Cell Tumors of the Ovary: Insights into the Progression from Primary to Recurrence.227例成人卵巢颗粒细胞瘤的分子图谱:对从原发至复发进展过程的见解
Lab Invest. 2025 Mar;105(3):102201. doi: 10.1016/j.labinv.2024.102201. Epub 2024 Nov 29.
3
The mechanism of NF-κB-TERT feedback regulation of granulosa cell apoptosis in PCOS rats.
多囊卵巢综合征大鼠中 NF-κB-TERT 反馈调节颗粒细胞凋亡的机制。
PLoS One. 2024 Oct 25;19(10):e0312115. doi: 10.1371/journal.pone.0312115. eCollection 2024.
4
Methylation, Gene Expression, and Risk Genotypes at the TERT-CLPTM1L Locus in Cervical Cancer.端粒酶逆转录酶-跨膜蛋白酶样1 (TERT-CLPTM1L) 基因座的甲基化、基因表达与宫颈癌风险基因型
Mol Carcinog. 2025 Jan;64(1):14-24. doi: 10.1002/mc.23822. Epub 2024 Oct 1.
5
Distinct transcriptional and prognostic impacts of TERT promoter mutations C228T and C250T in papillary thyroid carcinoma.TERT 启动子突变 C228T 和 C250T 在甲状腺乳头状癌中具有不同的转录和预后影响。
Endocr Relat Cancer. 2024 Jul 31;31(9). doi: 10.1530/ERC-24-0058. Print 2024 Sep 1.
6
TERT activation targets DNA methylation and multiple aging hallmarks.TERT 激活靶向 DNA 甲基化和多种衰老标志物。
Cell. 2024 Jul 25;187(15):4030-4042.e13. doi: 10.1016/j.cell.2024.05.048. Epub 2024 Jun 21.
7
Different Role of TRF1 and TRF2 Expression in Non-Small Cell Lung Cancers.TRF1和TRF2表达在非小细胞肺癌中的不同作用
Onco Targets Ther. 2024 Jun 4;17:463-469. doi: 10.2147/OTT.S461430. eCollection 2024.
8
BAP1 Loss, Nuclear Grading, and Nonepithelioid Features in the Diagnosis of Mesothelioma in Italy: Nevermore without the Pathology Report.意大利间皮瘤诊断中BAP1缺失、核分级及非上皮样特征:若无病理报告,绝不再如此。
J Pers Med. 2024 Apr 8;14(4):394. doi: 10.3390/jpm14040394.
9
Malignant Peritoneal Mesothelioma: An In-Depth and Up-to-Date Review of Pathogenesis, Diagnosis, Management and Future Directions.恶性腹膜间皮瘤:发病机制、诊断、治疗及未来方向的深入与最新综述
Cancers (Basel). 2023 Sep 25;15(19):4704. doi: 10.3390/cancers15194704.
10
C250T mutation: A potential biomarker of poor prognosis in metastatic melanoma.C250T突变:转移性黑色素瘤预后不良的潜在生物标志物。
Heliyon. 2023 Aug 6;9(8):e18953. doi: 10.1016/j.heliyon.2023.e18953. eCollection 2023 Aug.